Episode 461: Artificial Intelligence and Retinopathy of Prematurity Screening with Dr. Pete Campbell
Dr. Pete Campbell of the Casey Eye Institute joins to discuss applications of artificial intelligence for screening of retinopathy of prematurity. Relevant Financial Disclosures: Dr. Campbell is co-founder and CEO of Siloam Vision, which is commercializing UWF-OCT, UWF-SLO and AI for ROP.You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi